Jennifer B. Damico - 03 Mar 2026 Form 4 Insider Report for PFIZER INC (PFE)

Reporting relationship: SVP & Controller
Issuer ticker: PFE
Reported as of: 03 Mar 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 05 Mar 2026, 17:27:54 UTC
Prior SEC filing: 03 Mar 2026
Next SEC filing: 10 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Shanice A. Reid, by power of atty, for Jennifer B. Damico

Key filing fact

Jennifer B. Damico filed Form 4 for PFIZER INC (PFE) on 05 Mar 2026.

Key facts

This page summarizes Jennifer B. Damico's Form 4 filing for PFIZER INC (PFE).
4 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 05 Mar 2026, 17:27.

Change

Previous filing in this sequence was filed on 03 Mar 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001805617 Primary reporting owner

DAMICO JENNIFER B.

Relationship: SVP & Controller
Address: 66 HUDSON BOULEVARD EAST, ATTN: CORPORATE SECRETARY, NEW YORK
Signature: /s/ Shanice A. Reid, by power of atty, for Jennifer B. Damico
Signature date: 05 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PFE transaction

Common Stock

Award

Transaction value
Shares: +16,311
Change %: +135%
Price: $0.000000^*
Shares after: 28,352
Date: 03 Mar 2026
Ownership: Direct
Footnotes: F1

PFE transaction

Common Stock

Award

Transaction value
Shares: +5,408
Change %: +19%
Price: $0.000000^*
Shares after: 33,760
Date: 03 Mar 2026
Ownership: Direct
Footnotes: F1

PFE transaction

Common Stock

Tax liability

Transaction value
Shares: -826
Change %: -2.4%
Price: $26.62^*
Shares after: 32,934
Date: 04 Mar 2026
Ownership: Direct
Footnotes: F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PFE transaction Derivative

Stock Appreciation Rights

Award

Transaction value
Shares: +22,638
Change %
Price: $0.000000^*
Shares after: 22,638
Date: 03 Mar 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 22,638
Exercise price: $26.58
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

The reported transaction constitutes the grant of restricted stock units, which are subject to certain vesting requirements.

Footnote F2

The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon).

Footnote F3

The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.